Johnson & Johnson’s talc product removals and $700M settlement
Johnson & Johnson has faced long-running controversy over the safety of talc-based products. After FDA asbestos-limit concerns emerged decades earlier, the company removed talc-based baby powders from U.S. and Canadian markets in 2020. In 2024, it agreed to a $700 million settlement to resolve a nationwide class action over talc product safety, following prior major acquisitions and pandemic vaccine efforts.